Faculty Rank: Assistant Professor
Medical or Graduate Education:
Mayo Medical School
University of Chicago Children's Hospital - Pediatrics; Pediatric Emergency Medicine
Children's Memorial Hospital - Pediatric Hematology/Oncology
Bone cancer (bone sarcoma)
Brain tumor, pediatric
Leukemias, acute and chronic
Soft tissue sarcoma
Thrombotic diseases, pediatric
Clotting disorders in children
Pediatric & Adolescent Ambulatory Care Professional Building 1725 W. Harrison St. Suite 710 Chicago, IL 60612 Phone: (312) 942-3034 Fax: (312) 563-2317
View Larger Map • Driving Directions
Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to PubMed.gov). Listings go back five years.
Family Refusal of Chemotherapy for Pediatric Cancer Patients: A National Survey of Oncologists. Nassin ML, Mueller EL, Ginder C, Kent PM J. Pediatr. Hematol. Oncol. 2014 Nov 19 :. Metastatic Osteosarcoma to the Interventricular Septum: An Unusual Presentation in a Child. Taqatqa AS, Kent PM, Awad SM Pediatr Cardiol 2014 Jun 20 Insights into the genetic basis of familal hemophagocytic lymphohistiocytosis. Mittal N, Kent PM Pediatr Blood Cancer 2014 Jun 61(6):962-3. Survivorship in young patients with bone cancer. Greene M, Kobierska M, Kent PM, Piasecki P Curr Probl Cancer 2013 Jul-Aug 37(4):236-43. Future directions for pediatric and young adult bone sarcoma. Finney J, Kent PM, Batus M Curr Probl Cancer 2013 Jul-Aug 37(4):225-35. Surgery in malignant bone tumors. Gitelis S, Bayne CO, Frank JM, Filingham Y, Kent PM Curr Probl Cancer 2013 Jul-Aug 37(4):192-7. Introduction: Malignant primary bone tumors in children and young adults. Kent PM, Ording J, Dabrowski E, Shah K, Trafton L Curr Probl Cancer 2013 Jul-Aug 37(4):160-6. Clinical presentation of bone tumors in children and young adults. Kent PM, Trafton LW Curr Probl Cancer 2013 Jul-Aug 37(4):167-71. The pathophysiology of primary bone tumors in young adults and children. Miller I, Kent PM, Finney J Curr Probl Cancer 2013 Jul-Aug 37(4):172-80. The role of imaging of malignant bone tumors in children and young adults. Rana KA, Meyer J, Ibrahim S, Ralls M, Kent PM Curr Probl Cancer 2013 Jul-Aug 37(4):181-91. Radiation therapy in primary bone tumors for young patients. Dandekar V, Abrams R, Kent PM Curr Probl Cancer 2013 Jul-Aug 37(4):198-206. Standard chemotherapy for malignant bony tumors in children and young adults. Rafique A, Kent PM Curr Probl Cancer 2013 Jul-Aug 37(4):207-14. Metastatic and recurrent bone primary bone cancers. Mittal N, Kent PM, Ording J Curr Probl Cancer 2013 Jul-Aug 37(4):215-24. Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression. Morales La Madrid A, Nall MB, Ouyang K, Minor A, Raca G, Kent P, Miller I, Schleiermacher G, Janoueix-Lerosey I, Cohn SL. Pediatr Blood Cancer. 2013 2013 Feb 60(2):332-5. doi: 10.1002/pbc.24311. Epub 2012 Sep 19. Life-threatening Paraneoplastic Syndrome in a Child With Sarcoma of the Liver Cured by Emergency Resection. Fricchione MJ, Glenn N, Follmer R, Kent PM. J Pediatr Hematol Oncol. 2012 2012 Sep 19. [Epub ahead of print] Fetal MR imaging of posterior intracranial dural sinus thrombosis: a report of three cases with variable outcomes. Byrd SE, Abramowicz JS, Kent P, Kimura RE, Elias D, Heydeman PT. Pediatr Radiol. 2012 2012 May 42(5):536-43. doi: 10.1007/s00247-011-2287-9. Epub 2011 Oct 28. Sustained remission of Chronic Immune Thrombocytopenic Purpura with low dose hydroxyurea. Schloemer N, Lozovatsky M, McClain R, Kent P. Pediatr Blood Cancer. 2011 2011 Sep 57(3):528-9. doi: 10.1002/pbc.23153. Epub 2011 May 16. No abstract available. GLI1 genotypes do not predict basal cell carcinoma risk: a case control study. Watson A, Kent P, Alam M, Paller AS, Umbach DM, Yoon JW, Iannaccone PM, Walterhouse DO. Mol Cancer. 2009 2009 Nov 30 8:113. doi: 10.1186/1476-4598-8-113.
To watch a brief video of Paul M. Kent, MD, click the play button at the lower left corner of the video frame below.
(If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
I’m a pediatric oncologist. And what that means is I take care of patients who have a pediatric type of cancer, not that I take care of only children. That’s an important distinction. If it’s a disease — such as sarcoma, leukemia or lymphoma — that is more common in the childhood age group, we have the expertise, and we have the open research protocols, the availability of the best treatments — regardless of your age. Consequently, we take and see patients up to age 40.
The moment that I tell a family their child has cancer, they will never forget that moment. So the next thing has to be, “And this is how we’re gonna beat it.” And that time is something that’s frozen forever for this family. And we want to make sure that we are able to deliver on that promise.